“EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE” (2023) International Research Journal of Pharmacy, 14(11), pp. 21–25. doi:10.56802/kedfgd52.